MarketCap
Facebook
X
TelegramQuarterly report 2025-Q3
added 11-04-2025
Soleno Therapeutics ROA Ratio 2011-2026 | SLNO
Annual ROA Ratio Soleno Therapeutics
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -53.13 | -21.58 | -90.83 | -86.94 | -37.92 | -80.62 | -30.9 | -40.15 | -216.81 | -193.98 | -165.25 | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| -21.58 | -216.81 | -92.56 |
Quarterly ROA Ratio Soleno Therapeutics
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -36.66 | -66.82 | -72.59 | -45.68 | -45.68 | -47.25 | -67.45 | -97.55 | -89.34 | -108.51 | -99.37 | -50.87 | -70.0 | -69.95 | -74.23 | -57.44 | -70.59 | -64.62 | -53.45 | -33.53 | -31.2 | -15.72 | -30.58 | -42.31 | -48.65 | -57.32 | -47.45 | -31.51 | -41.21 | -44.58 | -38.39 | -27.27 | -76.69 | -116.4 | -169.36 | -169.85 | -210.0 | -200.74 | -114.68 | -159.29 | -316.96 | -434.47 | -615.08 | -473.01 | -573.2 | -515.72 | -358.05 | -100.19 | -100.19 | - | - | - | - | - | - | - | - | - | - |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| -15.72 | -615.08 | -132.28 |
ROA Ratio of other stocks in the Diagnostics research industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Anixa Biosciences
ANIX
|
-67.95 | $ 3.1 | 2.31 % | $ 101 K |  USA |
 |
Centogene N.V.
CNTG
|
-51.41 | - | -6.23 % | $ 30.6 M |  Germany |
 |
Brainsway Ltd.
BWAY
|
-8.53 | $ 24.05 | -2.67 % | $ 99.4 M |  Israel |
|
Akumin
AKU
|
-8.88 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Aspira Women's Health
AWH
|
-156.39 | - | -6.19 % | $ 10.5 M | USA |
 |
Biocept
BIOC
|
-103.93 | - | -13.05 % | $ 7.29 M | USA |
 |
Castle Biosciences
CSTL
|
3.43 | $ 39.16 | -0.89 % | $ 1.09 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
-34.96 | $ 33.54 | -5.15 % | $ 361 M |  China |
 |
Danaher Corporation
DHR
|
5.03 | $ 219.62 | -2.19 % | $ 161 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-22.47 | - | -61.36 % | $ 2.46 M | USA |
 |
Exact Sciences Corporation
EXAS
|
-14.58 | $ 102.3 | 0.05 % | $ 19 B | USA |
 |
Fulgent Genetics
FLGT
|
-3.5 | $ 26.24 | -0.61 % | $ 793 M | USA |
 |
BioNano Genomics
BNGO
|
-146.1 | $ 1.47 | -2.65 % | $ 1.87 M | USA |
 |
Guardant Health
GH
|
-29.37 | $ 110.48 | 0.68 % | $ 13.6 B | USA |
 |
Check-Cap Ltd.
CHEK
|
-6670.82 | - | - | $ 9.42 M | Israel |
 |
Oxford Immunotec Global PLC
OXFD
|
-0.77 | - | - | $ 562 M |  Britain |
 |
Chembio Diagnostics
CEMI
|
-37.2 | - | 0.22 % | $ 16.8 M | USA |
 |
Co-Diagnostics
CODX
|
-37.07 | - | - | $ 79.8 M | USA |
 |
DermTech
DMTK
|
-82.74 | - | -11.32 % | $ 2.94 M | USA |
 |
Lantheus Holdings
LNTH
|
15.78 | $ 66.68 | 0.56 % | $ 4.61 B | USA |
 |
Global Cord Blood Corporation
CO
|
5.87 | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
-16.33 | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
-34.28 | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
-33.12 | - | 0.12 % | $ 80.1 M | China |
 |
PRA Health Sciences, Inc.
PRAH
|
4.72 | - | - | $ 10.7 B | USA |
 |
DexCom
DXCM
|
8.64 | $ 74.0 | 0.87 % | $ 28.6 B | USA |
 |
CareDx, Inc
CDNA
|
-40.76 | $ 20.8 | 1.66 % | $ 1.12 B | USA |
 |
NeoGenomics
NEO
|
-4.81 | $ 12.4 | 0.16 % | $ 1.57 B | USA |
 |
Celcuity
CELC
|
-45.6 | $ 112.12 | -2.1 % | $ 4.42 B | USA |
 |
DarioHealth Corp.
DRIO
|
-61.65 | $ 10.3 | -6.02 % | $ 292 M | Israel |
 |
Enzo Biochem
ENZ
|
-30.41 | - | -8.98 % | $ 14.8 K | USA |
 |
Precipio
PRPO
|
-32.34 | $ 24.26 | -1.98 % | $ 31.5 M | USA |
 |
Personalis
PSNL
|
-30.08 | $ 9.97 | -0.2 % | $ 591 M | USA |
 |
Heska Corporation
HSKA
|
-3.4 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-121.47 | - | -20.0 % | $ 1.06 M | USA |
 |
Illumina
ILMN
|
-19.4 | $ 149.69 | -0.11 % | $ 23.8 B | USA |
 |
QIAGEN N.V.
QGEN
|
1.47 | - | - | $ 10.6 B |  Niderland |
 |
IQVIA Holdings
IQV
|
5.1 | $ 235.62 | -1.73 % | $ 42.7 B | USA |
 |
Thermo Fisher Scientific
TMO
|
6.51 | $ 592.16 | -2.61 % | $ 226 B | USA |
 |
Trinity Biotech plc
TRIB
|
0.78 | $ 0.87 | -4.13 % | $ 61.9 M |  Irlanda |
 |
Charles River Laboratories International
CRL
|
0.29 | $ 211.68 | -2.4 % | $ 10.9 B | USA |
 |
Twist Bioscience Corporation
TWST
|
-12.1 | $ 41.58 | -1.02 % | $ 2.49 B | USA |
 |
Medpace Holdings
MEDP
|
19.25 | $ 593.07 | -0.81 % | $ 18.4 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
5.39 | $ 182.35 | -0.21 % | $ 20.2 B | USA |
|
Biodesix
BDSX
|
-44.15 | $ 9.66 | -6.49 % | $ 1.25 B | USA |
 |
Motus GI Holdings
MOTS
|
-178.14 | - | -34.28 % | $ 263 K | Israel |
 |
Laboratory Corporation of America Holdings
LH
|
4.06 | $ 269.81 | 0.66 % | $ 22.6 B | USA |
 |
Mettler-Toledo International
MTD
|
26.64 | $ 1 392.8 | -0.63 % | $ 29.6 B |  Schweiz |
 |
ICON Public Limited Company
ICLR
|
4.69 | $ 185.89 | -0.23 % | $ 15.3 B | Irlanda |
 |
IDEXX Laboratories
IDXX
|
26.96 | $ 676.71 | -1.6 % | $ 55.8 B | USA |